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Abstract 22 
 23 
A dietary dose-response study with varying docosahexaenoic acid (DHA; 22:6n-3) inclusion 24 
levels (1 g/kg, 5 g/kg, 10 g/kg, 15 g/kg and 20 g/kg) was conducted with post-smolt (111 ± 2.6g; 25 
mean ± S.D.) Atlantic salmon (Salmo salar) over a nine week feeding period. Further diets included 26 
DHA at 10 g/kg in combination with either eicosapentaenoic acid (EPA; 20:5n-3) or arachidonic acid 27 
(ARA; 20:4n-6), both included at 10 g/kg, and a diet where both EPA and DHA were included at 5 28 
g/kg (total of 10 g/kg of long-chain polyunsaturated fatty acids, LC-PUFA). Fish were fed using a 29 
pair-feeding feeding regime to eliminate feed and energy intake variability. Fish were weighed every 30 
three weeks, and carcass, blood and tissue samples collected after nine weeks. Behavioural parameters 31 
were assessed weekly. A minor improvement in growth was seen with increasing inclusion of DHA. 32 
However, the addition of EPA provided a further improved growth response while addition of ARA 33 
had no effect on growth. An improvement in feeding behaviour was seen with increasing DHA up to 34 
10 g/kg, and addition of EPA or ARA had only minor effects on behavioural responses. Temporal 35 
differences were observed in the survival of fish, with the addition of ARA resulting in a progressive 36 
decline in survival relative to fish fed the other diets. In contrast, the survival of fish on the low DHA 37 
diet (1 g/kg) was initially high but declined from 6 weeks onwards. As expected, the fatty acid 38 
composition of whole body lipid largely reflected the diets. Deposition efficiency of dietary fatty 39 
acids was generally unresponsive to the different dietary treatments with the notable exception of 40 
DHA. At very low inclusion levels DHA deposition efficiency was substantially higher (~300 %) than 41 
that for all other inclusion levels (31 % to 58 %). The inclusion of EPA in the diet also had a positive 42 
effect on the deposition efficiency of DHA but EPA deposition efficiency was variable. Deposition 43 
efficiency of ARA was unaffected by DHA inclusion, but addition of either EPA or ARA resulted in a 44 
substantial reduction in the deposition efficiency of ARA. In the present study, the results suggested 45 
that inclusion of DHA of at least 10 g/kg diet is optimal. Addition of either EPA or ARA had a 46 
nominal influence on the effects of DHA, although inclusion of EPA appeared to improve 47 
performance. When the total n-3 LC-PUFA content of the diet was the same but consisted of either 48 
DHA alone or as a combination of EPA plus DHA the performance effects were similar, but 49 
behavioural effects in this study were more related to DHA content than total n-3 LC-PUFA content. 50 
51 
 3 
1. Introduction 52 
 The relatively static global supply of fish oil resources has increased the level of alternative 53 
(vegetable and terrestrial animal) oil resources being used in fish feeds (Tacon and Metian, 2008). 54 
Many alternatives have been evaluated in a wide range of fish species over the last few years and, in 55 
most cases, it has been demonstrated that high-level replacement of fish oils is possible (Sales and 56 
Glencross, 2010). However, most of the alternatives now commonly being used (e.g. rapeseed, 57 
soybean and poultry oils) are notable in their lack of long-chain polyunsaturated fatty acids (LC-58 
PUFA) and, with increasing use of these alternative lipid sources and the concomitant use of 59 
alternative protein resources rather than fish meals, some diets are beginning to encroach on 60 
documented dietary levels of essential fatty acids (EFA) for some species (Glencross, 2009). 61 
Most aquatic species have some form of requirement for EFA as dietary nutrients (reviewed 62 
by Glencross, 2009). However, which specific fatty acid (n-3 or n-6, long-chain or C18) satisfies EFA 63 
requirements, their concentration in the diet, and how the value of an EFA is influenced by the 64 
presence of other dietary fatty acids appears to vary markedly among species (Glencross and Smith, 65 
2001). It is generally considered that marine species have a higher, or more defined requirement, for 66 
the LC-PUFA docosahexaenoic acid (DHA; 22:6n-3) or eicosapentaenoic acid (EPA; 20:5n-3), while 67 
diadromous species have a lower requirement and some freshwater species appear to have no 68 
requirement at all for LC-PUFA (Bell et al., 1986; Castell et al., 1994; Tocher, 2003; Glencross, 69 
2009). 70 
Unlike most marine species salmonids possess the ability to elongate and desaturate α-71 
linolenic acid (LNA; 18:3n-3) to produce EPA and DHA (Castell et al., 1972a; b; Thomassen et al., 72 
2012). However, in the absence of dietary LNA or other n-3 LC-PUFA rainbow trout have been 73 
shown to produce elevated levels of 20:3n-9 (Castell et al. 1972c). It has been suggested that the ratio 74 
of 20:3n-9 to DHA in liver phospholipids of rainbow trout serves as an indicator of EFA deficiency 75 
(Castell et al. 1972b). In terms of the dietary requirement of salmonids for n-3 LC-PUFA, this has 76 
been reported to range from 10 g/kg to 25 g/kg of the diet depending on species and experimental 77 
conditions (reviewed by Glencross, 2009). The early studies of Castell et al. (1972a; 1972b) with 78 
rainbow trout (Oncorhynchus mykiss) focussed on the requirement for linoleic acid (LOA; 18:2n-6) or 79 
LNA and found that growth was significantly better with LNA over LOA or an EFA deficient diet. 80 
However, the value of LNA as an EFA for trout exists only because it has significant ability to 81 
desaturate and elongate LNA to the biologically active LC-PUFA, EPA and DHA (Castell et al., 82 
1972a,b; Thomassen et al., 2012). These studies also demonstrated that there was no requirement for 83 
n-6 PUFA by rainbow trout (Castell et al., 1972a,b), though this notion was later challenged by the 84 
assertion that trout may require small amounts of n-6, specifically arachidonic acid (ARA; 20:4n-6), 85 
for prostaglandin and leukotriene synthesis (Henderson et al., 1985; Villalta et al., 2008). 86 
Although the early work of Castell et al. (1972a, b) defined a requirement for n-3 PUFA, it 87 
was a series of studies on Atlantic salmon fry undertaken by Ruyter et al. (2000a) that went on to 88 
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examine the quantitative and qualitative EFA requirements for LOA, LNA and, EPA and DHA in 89 
combination. It was shown that inclusion of LNA, and EPA and DHA in combination both provided 90 
significant nutritional benefits to the fish. Of all treatments examined, the 50:50 combination of EPA 91 
and DHA at 10 g/kg provided the greatest benefit. Interestingly, Ruyter et al. (2000a) also showed 92 
poorer growth of fish fed 20 g/kg of either LNA or EPA and DHA. This was consistent with the 93 
earlier reports of Yu and Sinnhuber (1979), who also reported that excess levels of LC-PUFA had a 94 
negative impact on growth. Therefore, there is accumulating evidence that providing an excess 95 
amount of n-3 LC-PUFA in the diet can have adverse effects on growth and food utilization. 96 
However, in the work by Ruyter et al. (2000a) the roles of the LC-PUFA of DHA and EPA were only 97 
examined in combination. Recent studies with Asian seabass (Lates calcarifer; aka barramundi) have 98 
reported discrete effects of DHA alone or in the presence of EPA, and verified the synergistic 99 
importance of both (Glencross and Rutherford, 2011). Additionally, the influence of the n-6 LC-100 
PUFA, ARA, has also been assessed and showed some contrasting effects to that observed with the 101 
inclusion of EPA, reflective of the competing roles that these fatty acids have in the pathways for 102 
eicosanoid synthesis (Terano et al., 1986; Garg et al., 1990; Garg and Li, 1994; Bell et al., 1995). A 103 
more recent study by Codabaccus et al., (2012) also examined the response of post-smolt Atlantic 104 
salmon to DHA. However, this study showed no growth effects to the manipulation of the dietary 105 
fatty acid profile, but we believe this result was constrained by the design of the experiment.  106 
Based on the earlier work by Ruyter et al (2000a), it was hypothesized that post-smolt 107 
Atlantic salmon will have a quantitative dietary DHA requirement of around 10 g/kg. Based on 108 
studies with Asian sea bass it was also hypothesized that the response to this dietary level of DHA 109 
may be affected by the presence of other LC-PUFA in the diet (Glencross and Rutherford, 2011). The 110 
present study therefore examined the inclusion of incremental levels of dietary DHA on performance 111 
attributes of post-smolt Atlantic salmon. The study was not primarily designed to determine optimal 112 
feed specifications but rather aimed to specifically investigate the requirement for dietary DHA and 113 
its interaction with other dietary LC-PUFA. Accordingly, a paired-feeding strategy was adopted to 114 
eliminate the confounding effects of variation of intake of other dietary nutrients and energy. The 115 
study included a further three treatments to examine the effect of dietary EPA and ARA on the 116 
response of this species to dietary DHA. Whilst the primary parameter evaluated in this study was 117 
growth performance it was hypothesized that many of the dietary effects would be sub-clinical and 118 
therefore a range of biochemical, compositional, health and behavioural studies were also included to 119 
elucidate the specific mechanisms of DHA and possible interactions with other key LC-PUFA in the 120 
diet. 121 
122 
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2. Materials and Methods 123 
 124 
2.1 Diet manufacture and management 125 
 A single basal diet was formulated to provide protein and lipid at 460 g/kg and 200 g/kg diet 126 
at a gross energy level of 22.0 MJ kg-1 (estimated digestible protein and energy of 440 g/kg and 19.5 127 
MJ kg-1, respectively). Of the dietary lipid, 185 g/kg was vacuum-infused post-extrusion and it was at 128 
this point that the different treatments were made by infusing different oil blends. The fishmeal was 129 
defatted by hexane extraction followed by drying at 60 ºC for 24 h to remove all residual solvent. The 130 
nutrient compositions of the main dietary ingredients are presented in Table 1. To produce the basal 131 
diet pellets, the dry ingredients were blended in 30 kg batches to make a pellet mash using a 60 L 132 
upright Hobart mixer (HL600, Hobart, Pinkenba, QLD, Australia). The mash was pelletized using a 133 
laboratory-scale twin-screw extruder (MPF24:25, Baker Perkins, Peterborough, United Kingdom). 134 
Extruder configurations were as defined in Glencross et al. (2012). A single 130 kg batch of basal diet 135 
was extruded using the same operational parameters for consistency.  136 
 A series of five DHA inclusion levels (D1, D5, D10, D15 and D20) were created by blending 137 
oils including an algal-derived (Crypthecodinium sp.) DHA oil source (DHASCO) and a blend of 138 
butterfat and olive oil to provide the lipid base (Table 2). Three additional treatments were included to 139 
examine the accessory inclusion of ARA or EPA. The ARA was added as the fungal-derived 140 
concentrate (ARASCO) to provide inclusion levels of 10 g/kg each of ARA and DHA (D10A). As 141 
there was no equivalent EPA concentrate equivalent to DHASCO or ARASCO, anchovy oil 142 
containing both EPA and DHA in equal amounts was used to formulate the DHA/EPA diets, with 143 
addition to provide inclusion levels of either 10 g/kg (D10E) or 5 g/kg (D5E) each of EPA and DHA. 144 
Full diet compositions are given in Table 3. The oil blends were prepared prior to vacuum coating and 145 
were thoroughly mixed before being applied. The butterfat was melted at 60 ºC for 2 h and any 146 
remaining solids decanted to waste prior to addition to the oil blends. Dry basal pellets were placed in 147 
a mixer (Hobart, Sydney, Australia) and the prescribed allocation of oil blend applied whilst mixing, 148 
after which the bowl was sealed with a Perspex lid and a vacuum applied. Once all visible signs of air 149 
escaping from the pellets had ceased, the vacuum chamber was re-equilibrated to atmospheric 150 
pressure and the oil infused into the pellet.  151 
 152 
2.2 Fish management 153 
 Pre-smolt Atlantic salmon were sourced from Howietoun fish hatchery (Bannockburn, 154 
Scotland) and transferred to the Marine Environmental Research Laboratory (MERL, Machrihanish, 155 
Argyll, Scotland). At MERL the fish were allocated to two 10,000 L seawater tanks and on-grown to 156 
110.9 ± 2.61 g (mean ± S.D) prior to the experiment. All fish were anesthetised using benzocaine 157 
prior to handling. The fish were weighed on an electronic top-loading balance to 0.5 g accuracy and 158 
20 fish allocated to each of 24 x 500 L tanks. Fish were re-weighed at day 21, day 42 and finally on 159 
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day 62 of the experiment. The experiment was conducted in a flow-through, ambient water 160 
temperature, 500L x 24-tank array. Water temperature was 14.0 ± 0.82 ºC (mean ± S.D.) and 161 
dissolved oxygen was at 7.8 ± 0.60 mg L-1 (mean ± S.D.) for the duration of the 62-day experiment. 162 
Three replicates (tanks of 20 fish) were used for each treatment.  163 
 During the experiment, feeds were provided on a restricted pair-wise feeding regime with 164 
uneaten feed collected to accurately determine feed intake per tank (Helland et al., 1996). A 165 
correction factor was applied to recovered uneaten pellets to account for soluble losses incurred 166 
between feeding and collection to improve accuracy of feed intake assessment. The initial restrictive 167 
rations were estimated based on an 80 % demand as estimated for a 19.5 MJ kg-1 diet at 12 ºC using a 168 
bioenergetic model for salmon (B. Glencross, unpublished). Subject to all rations being consumed by 169 
each tank, the ration allocations were incrementally increased uniformly by 0.25 g fish-1 each week 170 
from a base allocation of 1.0 g fish-1. Total feed fed per fish is presented in Table 4. 171 
 172 
2.3 Sample preparation and analysis 173 
At the beginning of the study, six fish representative of the initial population were euthanized, 174 
dried of residual surface moisture and frozen for subsequent compositional analysis in three lots of 175 
two fish. At the end of the experiment (day 62), after final weighing, five fish from each tank were 176 
similarly sampled and frozen for compositional analysis. The fish from each tank were minced 177 
together after defrosting and a sample taken for dry matter analysis and another frozen prior to being 178 
freeze-dried. The freeze-dried whole fish samples were milled to a fine powder before being analysed 179 
for dry matter, nitrogen (protein), ash, total lipid content, and fatty acid compositions. Blood samples 180 
(~10 mL total) were collected from the caudal vein of an additional two fish per tank and pooled 181 
within a single Falcon™ tube, containing 100 IU of lithium heparin. About half the blood was 182 
transferred to three Eppendorf™ tubes before being centrifuged at 1000 x g for ~2 min to sediment 183 
the erythrocytes and the plasma transferred to a Cryotube™ prior to being frozen in liquid nitrogen. 184 
The remaining blood was kept on ice and haematological analysis performed within 24 h of collection 185 
(Scottish Agricultural College Veterinary Services, Penicuik, Scotland). Clinical biochemical analysis 186 
was performed on frozen plasma using an automated chemistry analyser (AU400, Olympus Optical 187 
Co. Ltd) using standard assay kits developed for the auto-analyser (Scottish Agricultural College 188 
Veterinary Services, Penicuik, Scotland). 189 
      Moisture and ash contents of diets and fish were determined according to standard procedures 190 
(AOAC, 2000). Dry matter was assessed gravimetrically following oven drying at 105 ºC for 24 h, 191 
and gross ash content was determined gravimetrically after combustion in a muffle furnace at 550 °C 192 
for 12 h. Energy contents of the diets were measured by bomb calorimetry using a Parr 6200 193 
calorimeter according to standard procedures. Crude protein levels were calculated from the nitrogen 194 
content (N × 6.25) using automated Kjeldahl analysis (Tecator Kjeltec Auto 1030 analyser, Foss, 195 
Warrington, UK). Lipid contents were determined gravimetrically after extraction according to Folch 196 
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et al. (1957). Fatty acid compositions were determined by gas chromatography of methyl esters 197 
essentially according to Christie (2003). Individual methyl esters were identified by comparison with 198 
known standards and by reference to published data (Ackman, 1980; Tocher and Harvie, 1988), and 199 
quantified using Chromcard for Windows (version 1.19). 200 
  201 
2.4 Behaviour analysis 202 
Two methods were used to assess the behavioural response of tanks of fish. Method one 203 
scored feeding activity after one round of feed had already been fed as described previously for Asian 204 
sea bass (Glencross and Rutherford, 2011). A score of 2 was given when fish actively came to the 205 
surface and pursued feed, a score of 1 for fish feeding actively but not breaking the surface to pursue 206 
feed, and a score of 0 for fish that were slow to feed and appeared lethargic in their behaviour. This 207 
semi-subjective assessment was carried out by the same person once a week for each of the nine 208 
weeks of the study. Scores were averaged across time to give a repeated-measures response to each 209 
tank, and each tank was used as a replicate within each treatment. This is similar to that which was 210 
reported in Glencross and Rutherford (2011). However, the behaviour of the salmon in this 211 
experiment was substantially different to that of the Asian sea bass in the work by Glencross and 212 
Rutherford (2011), with the fish always remaining timid and never being able to relate the presence of 213 
a person to feed allocation. As such the behaviour scoring was more difficult in the case of salmon. 214 
A second, more objective, indicator of feeding behaviour, the number of pellets remaining in 215 
the feed container after two rounds of feeding relative to the total number of pellets allocated, was 216 
determined. The fish were fed to a point of notable decline in active feeding before cessation of 217 
feeding. This assessment was also carried out by the same person once a week for each of the nine 218 
weeks of the study except weeks 5 and 7. Scores were again averaged across time to give a repeated-219 
measures response to each tank and each tank used as a replicate within each treatment. 220 
 221 
2.5 Physical health assessment 222 
At the end of the study, a series of physical condition features were noted and recorded for all 223 
fish within each tank. The incidence of conditions such as pectoral fin erosion, caudal fin reddening or 224 
erosion, skin lesions/scale loss, pin-heading and eye malformations were assessed to give a percentage 225 
value for each parameter for each tank. A systemic outbreak of amoebic gill disease (AGD) was also 226 
present in the facility during the experimental period at low levels and was controlled by giving all 227 
fish a 2 h freshwater bath treatment once a month. Accordingly, at week 9 an AGD gill score was 228 
given for each fish based on that reported by Taylor et al. (2009). The scoring for health parameters 229 
was carried out by the same person for all fish and at each time point. 230 
 231 
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2.6 Statistical analyses 232 
 All figures are mean ± SEM unless otherwise specified. Effects between D10, D20, D10A, 233 
D10E and D5E were examined by ANOVA using the software package Statistica (Statsoft®, Tulsa, 234 
OA, USA). Levels of significance were determined using an LSD planned comparisons test, with 235 
critical limits being set at P < 0.05. Effects of DHA inclusion level (D1, D5, D10, D15 and D20) were 236 
analysed by regression analysis. 237 
Relative deposition efficiency (%) of specific fatty acids (DHA, EPA, ARA, LNA and LOA) 238 
was calculated using the mean intake per fish in each tank and the mean gain in mass of specific fatty 239 
acids by fish in that tank, over the duration of the study, to give tank-specific values that were then 240 
used to derive a treatment mean. The formula used was based on that reported by Glencross et al., 241 
(2003), where FAf is the absolute amount of a specific fatty acid in the fish at the end of the study and 242 
FAi is the absolute amount of that specific fatty acid in the fish at the beginning of the study. FAc is 243 
the amount of that specific fatty acid that the fish consumed over the study period, such that:  244 
 245 𝐹𝑎𝑡𝑡𝑦  𝐴𝑐𝑖𝑑  𝐷𝑒𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛  𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦   % = 𝐹𝐴𝑓 − 𝐹𝐴𝑖𝐹𝐴𝑐 ×100 
246 
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3.  Results 247 
 248 
3.1 Fish growth, feed utilisation and survival 249 
Fish in this study generally grew at an equivalent rate to those reported in Codabaccus et al. 250 
(2012), and at a better rate than those reported by Miller et al. (2007), despite being pair-fed in the 251 
present study and to apparent satiety in the other studies. A significant effect of dietary fatty acid 252 
composition on growth (as final weight, weight gain and gain rate) after 9-weeks was observed (Table 253 
4a and 4b). No significant differences were seen among the different DHA inclusion levels when 254 
analysed using regression (Table 4a), but fish fed diet D10E had significantly better growth than fish 255 
fed the diets with the two lower and the two higher DHA inclusion levels (Table 4b). Interestingly, 256 
during this period of growth the fish fed the D10A treatment was best. 257 
             As intended, there were no significant differences in feed intake among any of the treatments 258 
(Table 4a,b). Some significant differences among the treatments for FCR were observed. Both of the 259 
EPA treatments showed significantly lower FCR than the lower DHA inclusion levels (D1 and D5). 260 
No significant improvements in FCR were noted with increasing DHA inclusion based on regression 261 
analysis (Table 4a). No other significant differences in FCR were present. 262 
No significant effects of treatment on survival were noted with increasing DHA content when 263 
based on regression, albeit P = 0.060). Fish fed the D10A treatment had the poorest survival of all 264 
treatments but, despite a difference of 11 % between this treatment and the treatment with highest 265 
survival (D5E), variability among replicates meant this was not significantly different (Table 4). 266 
However, notable were both the consistent decline in survival of fish in the D10A treatment and the 267 
sudden decline in survival from day 40 onwards, prior to the day 42 weighing event, in fish fed D1. 268 
 269 
3.2 Tissue composition and fatty acid retention 270 
The fatty acid composition of fish largely reflected that of the dietary treatments (Table 5). As 271 
expected there was an increasing percentage of DHA in the tissues of fish fed increasing dietary DHA 272 
content. However, the concentration of DHA was typically always marginally higher than that of the 273 
diet. Somatic EPA content declined substantially from the initial fish in all treatments and at the end 274 
of the experiment represented around 3 % of total fatty acids (Table 5).  Even with the treatment 275 
containing a higher level of added EPA it still only represented 4 % of the total fatty acids. Somatic 276 
ARA was low in fish fed all treatments (< 1 %) except for fish fed diet D10A where it increased to 277 
around 3 % of the total fatty acids in the fish (Table 5).  Total SFA content of fish at the end of the 278 
experiment was generally very consistent at around 30 % of total fatty acids (range 29 – 32 % of total 279 
fatty acids). MUFA content of fish from each of the treatments ranged from 35 % in the initial 280 
population sample to 51 % in fish fed the D5 treatment. Among most treatments there was more 281 
variation in MUFA content than the SFA content (range 44 % to 51 %). The proportions of total LC-282 
PUFA in the whole body tissues of the treatment diet fed fish varied from 11 % to 17 %. It was 283 
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highest in the treatment fed the D20 diet and lowest in the fish fed the D5 diet. However, the initial 284 
fish had the highest LC-PUFA content of all at 23% of total fatty acids. There was only a minor 285 
treatment effect in whole body content of LC-PUFA with increasing DHA inclusion in the diet (range 286 
11% to 17%). Even the lowest inclusion level of LC-PUFA (the D1 diet) was relatively conserved at a 287 
total LC-PUFA level of 12% of total fatty acids. 288 
There was considerable difference in the fatty acid deposition efficiencies of the different 289 
PUFA and LC-PUFA. DHA deposition efficiency was the most dramatically affected by DHA 290 
inclusion level, but not by the inclusion of either EPA or ARA in the diet. At the lowest inclusion 291 
level of DHA the deposition efficiency exceeded 300 %, but as DHA inclusion increased there was a 292 
curvilinear decline in deposition efficiency such that at the next inclusion level of DHA (D5) retention 293 
had declined to around 58 % and by the highest DHA inclusion level (D20) the deposition efficiency 294 
had declined to just over 30 % (Fig. 1a).  295 
The deposition efficiency of EPA was clearly affected by DHA inclusion level, and also by 296 
the inclusion of either EPA or ARA in the diet. At the lowest inclusion level of DHA, negative 297 
deposition efficiencies of EPA were observed. Deposition efficiency of EPA increased in a curvilinear 298 
fashion with increasing DHA in the diet before declining again to negative deposition efficiency at the 299 
highest DHA inclusion (Fig. 1b). However, among the D10, D10A and D10E diets there were marked 300 
differences. Addition of ARA reduced EPA deposition efficiency to -18 %, while inclusion of EPA or 301 
DHA increased it to 18 % or 28 %, respectively.  302 
In contrast, the deposition efficiencies of ARA, LNA and LOA were largely unaffected by 303 
DHA inclusion level with, in most cases, a consistent level of retention of each of the respective fatty 304 
acids. However, the level of retention of each fatty acid varied substantially among each other. Thus, 305 
ARA retention was generally high at around 180 %, and addition of EPA or ARA to the diet at the 10 306 
g/kg inclusion level reduced ARA retention to around 40% (Fig. 1c). The lower inclusion level of 307 
EPA had little effect on the efficiency of ARA retention. Deposition efficiency of LNA was also 308 
largely unaffected by DHA inclusion level (Fig. 2a). Although there was some variation in the LNA 309 
deposition efficiency there were no consistent patterns in response to DHA dose, or EPA or ARA 310 
inclusion. Similarly, deposition efficiency of LOA was also unaffected by DHA inclusion level, or the 311 
inclusion of ARA or EPA in the diet (Fig. 2b).  312 
 313 
3.3 Fish behaviour  314 
There were some significant differences among the treatments in the assessed behaviour 315 
indices (Fig. 3a,b). There was a relatively clear and significant dose response effect between both 316 
behavioural indices and the DHA content of the diet. The effect was most obvious with the more 317 
subjective assessment of a behaviour score, but these results were a direct inverse reflection of the 318 
completely objective assessment based on the proportion of pellets remaining after a defined feeding 319 
period. Both the EPA treatments (D10E and D5E) and the ARA treatment (D10A) showed improved 320 
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behaviours relative to the low LC-PUFA diet (D1), although these effects could not be fully 321 
discriminated from dietary DHA content. 322 
 323 
3.4 Plasma chemistry 324 
There were several significant differences among the plasma chemistry parameters relative to 325 
dietary treatment (Table 6). Only those parameters that showed significant effects that could be 326 
clearly attributed to dietary treatment are discussed below. 327 
There was a significant increase in plasma activities of the liver marker enzymes, alanine 328 
aminotransferase and asparagine aminotransferase, with the inclusion of ARA in the diet, but varying 329 
the levels of DHA or inclusion of EPA had little or no effect on their activities. Although there were 330 
significant differences in activities of glutamate dehydrogenase among the treatments a consistent 331 
pattern was not clearly observed. Creatinine levels were not significantly influenced by the level of 332 
DHA in the diet, but were significantly affected by the inclusion of ARA or EPA. Plasma calcium 333 
levels were significantly different among the treatments with a pattern suggesting a trend towards 334 
lower concentrations with increasing dietary DHA. The addition of EPA to the diet increased plasma 335 
calcium to significantly greater levels than those in fish fed the equivalent diet with DHA, though 336 
addition of ARA did not have the same effect. Plasma cholesterol levels were higher in fish fed the 337 
diet D10E. Red blood cell counts showed a significant suppression in the ARA treatment relative to 338 
the EPA treatment and also some of the DHA treatments but there did not appear to be a dose 339 
response to dietary DHA. 340 
 341 
3.5 Physical health assessment 342 
A range of physical pathology signs were assessed at week 9 (Table 7). It was notable that 343 
fish fed the low LC-PUFA diet (D1) showed few signs of physical pathologies. Increasing dietary 344 
DHA initially increased signs of physical pathology (D5 and D10) but these declined at higher levels 345 
(D15 and D20. The only notable effects attributable to EPA or ARA inclusion were increased 346 
incidence of pectoral fin erosion (D10E) or scale-damage (D10A).  347 
 348 
  349 
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4. Discussion 350 
 351 
4.1 What is so essential about essential fatty acids? 352 
The results from the present study provide empirical evidence of the roles of DHA and DHA 353 
in combination with either EPA or ARA in the diets of Atlantic salmon. Despite much evidence of the 354 
essentiality of dietary n-3 LC-PUFA, the present results suggest that the essentiality is relatively 355 
minor in salmon. However, the findings support that, while DHA alone can satisfy most requirements, 356 
the addition of EPA stimulates performance on a range of levels beyond that achieved with DHA 357 
alone. This suggests that EPA plays an equally important role in lipid metabolism in this species. 358 
Notably, dietary EPA along with DHA promotes better growth and health than that achieved by the 359 
same level of DHA alone suggesting potential of distinct roles for each LC-PUFA. It was also shown 360 
that the inclusion of ARA in addition to DHA had little effect on growth, but had effects on animal 361 
health. The outcomes of the present study in salmon were generally consistent to those reported in a 362 
similar study with Asian seabass (barramundi), although the current study also showed distinct 363 
differences, particularly in regards to the clinical observations (Glencross and Rutherford, 2011). 364 
These findings raise the question of why such differences between Atlantic salmon and Asian sea bass 365 
were observed and whether they relate to the environmental preferences/lifecycle of each species. To 366 
address this question it is pertinent to first consider the effects in relation to previous research in this 367 
area to examine why some findings were different and others similar. 368 
It had been reported that the dietary requirement of salmonids for n-3 LC-PUFA was in the 369 
range from 10 g/kg to 25 g/kg of the diet depending on species and experimental conditions (see 370 
Glencross, 2009). The first comprehensive series of studies on EFA requirements of a salmonid were 371 
those of Castell et al. (1972a, b) with rainbow trout (Oncorhynchus mykiss). In those early studies, 372 
fish were fed one of four diets in which treatments included a fat-free diet, a diet in which the 50 g/kg 373 
lipid in the diet was provided as 18:1n-9, a diet with 40 g/kg 18:1n-9 and 10 g/kg LOA, and a diet 374 
with 40 g/kg 18:1n-9 and 10 g/kg LNA. The results of this work demonstrated that salmonids had a 375 
defined n-3 requirement, albeit as LNA in this case. However, the value of LNA as an EFA for trout 376 
was proposed to exist only because it had significant ability to desaturate and elongate LNA to the 377 
biologically active LC-PUFA, EPA and DHA (Tocher, 2003). In the present study it was interesting 378 
to note that the fish fed the D1 diet (albeit not completely devoid of LC-PUFA) showed relatively 379 
good survival and growth. Indeed classic signs of EFA deficiency were not observed even after 62 380 
days of the experiment. However, the most obvious feature of fish fed that diet was the sudden decline 381 
in performance after about 40 days. If the initial decline in survival around day 7 is discounted 382 
(probably due to handling losses) then the effects observed on survival in this experiment are even 383 
more telling. The results provide good support that the fish were relying on endogenous stores of LC-384 
PUFA during this initial period before levels reached critical limits. Interestingly, if the growth 385 
response to DHA dose is examined solely from week 6 onwards a much clearer response to DHA can 386 
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be observed, which further affirms the notion of a requirement for this fatty acid and also that the 387 
optimal requirement level is around 10 g/kg. In retrospect it would have been of value to have 388 
continued this study for longer to allow these effects to consolidate. 389 
Over the past decades, since the foundation work of Castell (1972a, b), there have been 390 
further studies to ascertain what the critical requirement (quantitative or qualitative) might be for the 391 
n-3 LC-PUFA, EPA and DHA, in salmonid species (Brodtkorb et al., 1997; Ruyter et al., 2000a,b). 392 
An important methodological point of difference in the present study, compared to previous studies, 393 
was the use of a pair-fed feeding regime to isolate other nutrient intake effects. In using this strategy 394 
we have demonstrated that the requirement for DHA by Atlantic salmon is relatively minor, and have 395 
been able to isolate the confounding effects of feed intake variability and thereby remove protein and 396 
energy intake effects from the interpretation.  397 
It has also been previously reported that an excess amount of n-3 LC-PUFA in the diet can 398 
have an adverse effect on growth and food utilization by fish. An increase in EPA or DHA content to 399 
four-times the proposed requirement level reportedly resulted in poorer growth and feed efficiency, 400 
and the fish showed signs of EFA deficiency (Takeuchi and Watanabe, 1976). However, almost every 401 
modern salmonid diet tends to have lipid levels almost double those used in the 1970’s and 1980’s 402 
and, until recently, dilution of fish oil with alternatives (largely vegetable oils), these diets also had 403 
EPA + DHA inclusion levels considerably above the reported threshold without the apparent negative 404 
effects of inclusion of high amounts of n-3 LC-PUFA reported previously (Takeuchi and Watanabe, 405 
1976; Yu and Sinnhuber, 1976; 1979). However, some recent studies have demonstrated that high 406 
inclusion levels of LC-PUFA can have a significant negative effect on fish performance and health 407 
(Ruyter et al., 2000a; Ostbye et al., 2011; Betancor et al., 2011; Glencross and Rutherford, 2011). In 408 
the present study, such negative effects with the highest inclusion level of DHA, or a similar LC-409 
PUFA inclusion level of EPA and DHA, did not result in increased mortalities, levels of physical 410 
pathologies, or aberrations in plasma biochemistry or haematology.  411 
Formative studies by Ruyter et al. (2000a,b) used a series of trials on Atlantic salmon fry to 412 
determine their quantitative (0, 1, 2, 5, 10 and 20 g/kg of the diet) and qualitative requirements for 413 
LOA, LNA, and EPA and DHA in combination. These diets had relatively low lipid levels (~80 g/kg) 414 
in which the inclusion of LNA, and EPA and DHA in combination both provided significant benefits 415 
to the fish. The combination of EPA and DHA at 12.5 % total fatty acids provided the greatest benefit 416 
of all the treatments studied. While the data generally support this, the effects observed in the present 417 
study with post-smolt Atlantic salmon where not as dramatic.  418 
 419 
4.2 Fish growth and feed utilisation 420 
The growth of the fish in the present study, using the pair-fed regime, demonstrated that the 421 
stimulatory effect of DHA is minor at best. Indeed, although addition of EPA to the diet produced a 422 
significant improvement in growth relative to that observed in fish fed the low LC-PUFA diet, the 423 
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effect was still not as pronounced as that reported in some other species (reviewed by Glencross, 424 
2009). However, this observation showed that, while DHA may be important to development in this 425 
species, it cannot be provided in exclusion to EPA and indeed low levels of dietary LNA may be 426 
sufficient to offset the requirements for either LC-PUFA based on the fact that Atlantic salmon has 427 
demonstrated capacity for endogenous LC-PUFA biosynthesis (Tocher et al., 2003). However, despite 428 
evidence of the importance of dietary EPA in addition to DHA, further exploration of the relationship 429 
between the n-3 LC-PUFA and the importance of the ratios between these key PUFA is required 430 
(Furuita et al., 1998). 431 
A potential negative aspect of using a pair-fed feeding regime though is that the fish will 432 
grow somewhat slower than that expected of fish fed to satiety. However, in the present experiment 433 
the growth rates of the fish were equal to or better than that of Atlantic salmon parr and post-smolt fed 434 
to satiety in other recently published works (Miller et al., 2007; Codabaccus et al., 2012). Ironically 435 
the fish in the present study doubled their weight in 62 days compared with those in the study of 436 
Codabaccus et al. (2012) which doubled their weight from 71 g to 148 g in 75 days. However, 437 
consistent with the present study, Codabaccus et al. (2012) also found limited influence of the fatty 438 
acid composition on the growth or feed utilisation by post-smolt Atlantic salmon. These authors also 439 
stated that varying the ratio of EPA to DHA had no significant effect on growth or feed utilisation in 440 
post-smolt Atlantic salmon. Other studies with Atlantic salmon have shown that fish grew best with 441 
an inclusion of 10 g/kg LC-PUFA in their diet, when this was provided as an equal ratio of EPA to 442 
DHA (Ruyter et al., 2000a). Rainbow trout also grew best with an EPA to DHA ratio of 1 : 1, but with 443 
a total LC-PUFA inclusion level of 3 g/kg (Watanabe and Takeuchi, 1976). However, these authors 444 
also reported that EPA could be omitted from the diet and the LC-PUFA supplied solely as DHA to 445 
achieve the same effect (Watanabe and Takeuchi, 1976). Arguably this might also be possible with 446 
Atlantic salmon based on the present results, although the marginal improvements in performance 447 
observed with both EPA and DHA in the diet suggested both these LC-PUFA are possibly required. 448 
 449 
4.3 Tissue composition and fatty acid retention 450 
The changes in tissue fatty acid composition of fish fed each diet were consistent with those 451 
reported in most other studies on fish fed different lipid sources in that the tissue fatty acids were 452 
largely reflective of the respective diets (Sargent et al., 1999). However, it is the subtleties around the 453 
examination of the mass-balance relationship between dietary and tissue fatty acid compositions 454 
through the analysis of the deposition efficiency that often show distinct differences in the utilisation 455 
of different dietary fatty acids, particularly in the case of DHA intake (Glencross et al., 2003; 456 
Glencross and Rutherford, 2011).  457 
The observation that DHA deposition efficiency decreased with increasing dietary DHA were 458 
consistent with other reports on utilisation of this fatty acid (Glencross et al., 2003; Glencross and 459 
Rutherford, 2011). At the lowest inclusion level (1 g/kg) the very high deposition efficiency (>300%) 460 
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suggested that there was high conservation and/or possible endogenous synthesis of DHA (Glencross 461 
et al., 2003; Turchini and Francis, 2009). Certainly it is well established that Atlantic salmon have this 462 
capability (Tocher et al., 2003; Thomassen et al., 2012). The negative deposition efficiency values of 463 
EPA at both low and high DHA levels supports the position that some chain elongation and 464 
desaturation of precursor fatty acids occurred, but this pattern of EPA deposition efficiency contrasts 465 
with that observed in a similar study on Asian sea bass where there was clear retroconversion of DHA 466 
to produce EPA (Glencross and Rutherford, 2011). However, the curvilinear response in EPA 467 
deposition efficiency, peaking at a DHA inclusion level of 10 g/kg, is perhaps also supportive of 468 
defining the optimal dietary inclusion level of DHA. As expected, the addition of EPA to the diet 469 
resulted in relatively low deposition efficiency of EPA, but the addition of ARA to the diet produced 470 
an even more interesting response in that it also induced a negative deposition efficiency of EPA. This 471 
may be attributable to an increase in flux of EPA in the eicosanoid pathways, the activity of which 472 
may have been heightened by the additional dietary ARA (Bell et al., 1995; Ghioni et al., 2002). 473 
Notably there is a distinct symmetry in EPA retention between EPA and ARA diets, and this 474 
counteractive concentration/response effect has been noted in other species (Xu et al., 2010). The 475 
deposition efficiency of ARA was substantially higher (~180 %) than that reported in the counterpart 476 
study (~120 %) with Asian sea bass (Glencross and Rutherford, 2011). ARA retention in Atlantic 477 
salmon was largely unaffected by DHA inclusion, although the addition of EPA or ARA to the diet at 478 
the 10 g/kg inclusion level resulted in a significant reduction in ARA retention to around 40 %, 479 
although there were few effects of varying DHA inclusion level. This observation on ARA retention 480 
contrasts with the competing symmetry effect noted for EPA deposition efficiency with EPA and 481 
ARA inclusion. 482 
The absence of any clear dose response effects of DHA on LNA (or LOA) deposition 483 
efficiency suggested that this C18 PUFA appeared to be playing a limited role in DHA supply through 484 
possible elongation and desaturation processes. This may be being restricted by the relatively low 485 
levels of LNA in the diet (<1% of total fatty acids). 486 
 487 
4.4 Fish behaviour 488 
Previous studies on DHA dose response effects in Asian sea bass reported some distinct 489 
behavioural elements attributed to DHA (Glencross and Rutherford, 2011). Therefore, feeding 490 
behaviour was examined in the present study to determine if there was also a dose-response effect of 491 
DHA in Atlantic salmon. Although salmon were more skittish in their behaviour compared to Asian 492 
sea bass, a relative change in behaviour was still noted among the different DHA treatments. In the 493 
present study, the complications in the behavioural assessment compared to that done in Asian sea 494 
bass (Glencross and Rutherford, 2011) required both a reassessment of the behaviour score 495 
parameters and also an additional, more objective, feeding behaviour assessment and, combined, they 496 
provide confidence in our interpretation. Both methods showed that positive feeding behaviour 497 
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responded in a dose-response manner to increasing inclusion of DHA. This effect could not be 498 
attributed to either EPA or ARA as the inclusion of DHA in each of the diets clearly accounted for the 499 
responses observed and the addition of the other LC-PUFA did not alter these responses. Whether this 500 
effect was via changes to brain function or visual development is unclear, but further analysis of brain 501 
and eye compositions of fish from such a dose-response design may help clarify this issue (Tocher 502 
and Harvie, 1988; Crawford, 1992; Brodtkorb et al., 1997). Interestingly, earlier work had more 503 
strongly implicated dietary EPA as having a greater influence on the composition of lipids in neural 504 
tissues, though an effect of DHA was also noted (Mourente and Tocher, 1992; Brodtkorb et al., 1997). 505 
 506 
4.5 Fish health and plasma chemistry  507 
There have been many reports examining the effects of LC-PUFA (both n-3 and n-6) on the 508 
health of fish (Thompson et al., 1996; Richard et al., 2007; Ostbye et al., 2009; Betancor et al., 2011). 509 
In the present study, the focus was on both a clinical assessment of physical signs of EFA deficiency 510 
(poor growth, lesions, fin erosion) and also measurement of biochemical markers in plasma. Most 511 
notable was the response to dietary ARA as indicated by increased scale damage/skin lesions. The 512 
reduction in the level of fin damage with increasing levels of n-3 LC-PUFA was consistent with other 513 
studies, although the relatively low levels of fin damage in the low LC-PUFA diet (D1) were perhaps 514 
surprising (Castell, 1972a, b; Ruyter et al., 2000a). 515 
The plasma biochemical markers perhaps provided a more objective assessment of the roles 516 
of DHA, EPA and ARA in fish health, and in particular liver function (Glencross and Rutherford, 517 
2011). However, the number of treatments and tests involved meant that significant, but clinically 518 
irrelevant, effects may be observed and, therefore, the focus was on effects related to dose response, 519 
or relative response to corresponding inclusion of different LC-PUFA. Notably, the present study with 520 
Atlantic salmon showed a contrasting result to osmotic balance issues observed previously in Asian 521 
sea bass in the relative absence of EPA in the diet (Glencross and Rutherford, 2011). In Atlantic 522 
salmon there was little evidence of perturbations in urea, potassium or chloride levels. This suggested 523 
that EPA, which plays an important role in regulating plasma osmolarity through eicosanoid 524 
metabolism, was not particularly restricted in this study (Henderson et al., 1985; Beckman and 525 
Mustafa, 1992). This could be a sign that EPA requirements for Atlantic salmon are either low, or that 526 
endogenous biosynthesis was sufficient to maintain homeostasis. 527 
More notable in the present experiment though were the changes in liver enzyme markers 528 
such alanine aminotransferase, which showed an acute response to the presence of ARA, but was less 529 
responsive to the inclusion of DHA or EPA. Other liver marker enzymes such as glutamate 530 
dehydrogenase, however, also showed a dose response to dietary DHA, whilst still being elevated by 531 
ARA inclusion. Inclusion of EPA resulted in a lower level of this enzyme activity in the plasma. 532 
These observations provide some support to negative effects of ARA and DHA at high inclusion 533 
levels (in the absence of EPA) on the liver health of this species. 534 
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 535 
4.6 Implications and conclusions 536 
The present study showed that Atlantic salmon were not highly sensitive to dietary LC-PUFA 537 
manipulation and could perform relatively well with only low dietary levels of these fatty acids. 538 
However, the data indicated that dietary inclusion of 10 g/kg or above of DHA generally improved 539 
growth, feed conversion and feeding behaviour compared to fish fed a diet with 1 g/kg of DHA, albeit 540 
not all parameters were consistently significant. It was notable that the addition of EPA to the diet 541 
resulted in further improvements to growth and feed conversion, but did not appear to have an impact 542 
on feeding behaviour. In contrast to the results observed in similar studies, the absence of EPA in the 543 
diet did not induce any major pathologies (Glencross and Rutherford, 2011). Therefore, it is 544 
recommended, based on these findings, that at least 10 g/kg of DHA are required for optimal 545 
performance, but that 20 g/kg of EPA + DHA is preferable. Further investigation of whether the ratio 546 
of EPA to DHA can be altered and still achieve similar performance is required. 547 
 548 
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Figure legends 739 
 740 
Figure 1. Deposition efficiency (%) of DHA (a), EPA (b) and ARA (c) in fish from each of the 741 
experimental treatments. Treatments are indicated by (●) for those diets with 742 
incremental inclusion levels of DHA. Those diets with equivalent amounts of EPA (○) 743 
and ARA (∆) are also indicated. Error bars show the pooled SEM. 744 
 745 
Figure 2. Deposition efficiency (%) of LNA (a) and LOA (b) in fish from each of the 746 
experimental treatments. Treatments are indicated by (●) for those diets with 747 
incremental inclusion levels of DHA. Those diets with equivalent amounts of EPA (○) 748 
and ARA (∆) are also indicated. Error bars show the pooled SEM. 749 
 750 
Figure 3.  Assessment of the behavioural responses of groups of fish within each treatment (n=3 751 
tanks, error bars show the SEM for each treatment) using either of two assessment 752 
methods. (a) After two rounds of feeding in each tank the number of pellets remaining 753 
to be fed as a percentage of the total amount being fed was recorded, and (b) Fish were 754 
assessed as being highly-active (2), moderately active (1) or slow and lethargic (0) in 755 
terms of their response to being fed. Treatments are indicated by (●) for those diets 756 
with incremental inclusion levels of DHA. Those diets with equivalent amounts of 757 
EPA (○) and ARA (∆) are also indicated. 758 
759 
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Tables and Figures 760 
 761 
Table 1. Nutrient compositions of major dietary ingredients (all values are g/kg DM unless 762 
otherwise indicated).  763 
 764 
Ingredient SPI WF WG DF FO DHA ARA OO BF 
          
Dry matter (g/kg) 93.7 87.7 93.1 94.8 99.7 99.9 99.6 99.9 99.9 
Protein 94.6 12.6 82.2 71.8 0.4 0.6 0.8 0.9 0.6 
Fat 1.1 1.1 2.9 2.0 94.0 96.4 92.9 97.3 94.6 
Carbohydrate 1.0 85.7 14.2 8.4 5.6 3.0 6.3 1.8 4.8 
Ash 3.3 0.6 0.7 17.8 0.0 0.0 0.0 0.0 0.0 
Gross Energy (kJ/g) 22.6 16.0 21.7 18.7 39.1 39.1 38.4 39.3 37.5 
 
All fatty acids are %TFA         
14:0 0.6 0.0 0.0 6.7 8.3 9.5 0.9 0.0 11.8 
16:0 17.3 19.8 19.6 22.7 18.7 25.5 11.7 11.3 27.0 
18:0 4.7 1.9 1.5 5.3 3.4 0.9 7.7 3.2 12.1 
Total SFA 24.6 21.7 21.1 38.2 34.5 37.8 33.5 15.2 63.3 
16:1n-7 0.8 1.0 0.0 7.1 10.2 1.9 0.3 0.8 1.0 
18:1n-9 24.4 14.0 13.5 14.3 12.5 2.0 7.1 0.0 0.0 
18:1n-7 1.9 1.2 1.0 0.0 0.0 0.0 0.0 73.0 31.4 
Total MUFA 28.0 16.1 15.5 21.3 24.2 4.2 8.1 76.1 33.6 
18:2n-6 41.7 56.0 59.7 1.8 1.3 0.5 0.0 8.2 3.1 
18:3n-3 4.6 3.7 2.9 0.0 0.7 0.1 0.1 0.5 0.0 
Total C18 PUFA 46.2 59.6 62.6 3.6 5.3 1.5 3.1 8.6 3.1 
20:4n-6 0.0 0.0 0.0 1.5 1.1 0.9 49.7 0.0 0.0 
20:5n-3 0.0 1.3 0.8 13.2 16.9 1.9 0.2 0.0 0.0 
22:5n-6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 
22:6n-3 0.0 1.3 0.0 21.2 14.5 50.8 0.0 0.0 0.0 
Total LC-PUFA 1.3 2.5 0.8 35.9 33.7 56.3 55.3 0.0 0.0 
Total n-3 4.6 6.2 3.7 36.2 35.1 51.8 0.7 0.5 0.0 
Total n-6 41.7 56.0 59.7 3.3 3.9 6.1 57.6 8.2 3.1 
n-3 : n-6 0.1 0.1 0.1 10.9 9.0 8.5 0.0 0.1 0.0 
          
SPI : Soy protein isolate, WF : Wheat flour, WG : Wheat gluten, DF : Defatted fishmeal, FO : Fish 765 
oil, DHA : DHASCO, ARA : ARASCO, OO : Olive oil, BF : Butterfat. 766 
  767 
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Table 2. Formulations of the experiment diets (all values are g/kg).  768 
 769 
 D1 D5 D10 D15 D20 D10A D10E D5E 
         
Defatted Fish meal a 300.0 300.0 300.0 300.0 300.0 300.0 300.0 300.0 
Pregelled starch b 60.0 60.0 60.0 60.0 60.0 60.0 60.0 60.0 
Wheat gluten b 60.0 60.0 60.0 60.0 60.0 60.0 60.0 60.0 
Wheat flour b 155.0 155.0 155.0 155.0 155.0 155.0 155.0 155.0 
Soy Protein Isolate c 221.0 221.0 221.0 221.0 221.0 221.0 221.0 221.0 
Fish oil a 0.0 0.0 0.0 0.0 0.0 0.0 75.0 30.0 
Olive oil d 92.5 88.3 82.0 77.8 71.5 68.3 55.0 77.5 
DHASCO e 0.0 8.4 21.0 29.4 42.0 21.0 0.0 0.0 
ARASCO e 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 
Butter fat f 92.5 88.3 82.0 77.8 71.5 68.3 55.0 77.5 
L-Histidine g 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 
L-Lysine g 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 
DL-Methionine g 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 
L-Threonine g 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Yttrium oxide h 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
CaPO4 g 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Vitamin/minerals i* 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
         
a Fish meal (prior to being defatted): Chilean anchovy meal and oil, Skretting Australia, Cambridge, TAS, Australia. b Wheat 770 
gluten, wheat flour and pregelatinised starch: Manildra, Auburn, NSW, Australia.  c Soy protein isolate: ADM, Decatur, IL, 771 
USA.  d Refined olive oil: Conga Foods, Coburg North, VIC, Australia. e DHASCO and ARASCO oils: HuaTai BioPharm 772 
Inc, Deyang, Sichuan, China. f Butterfat: Woolworths Dairies, Bella Vista, NSW, Australia. g Amino acids and monocalcium 773 
phosphate: BEC Feed Solutions, Carole Park, QLD, Australia.. h Yttrium oxide: Stanford Materials, Aliso Viejo, California, 774 
United States. i* Vitamin and mineral premix includes (IU kg-1 or g/kg of premix): Vitamin A, 2.5MIU; Vitamin D3, 0.25 775 
MIU; Vitamin E, 16.7 g; Vitamin K,3, 1.7 g; Vitamin B1, 2.5 g; Vitamin B2, 4.2 g; Vitamin B3, 25 g; Vitamin B5, 8.3; 776 
Vitamin B6, 2.0 g; Vitamin B9, 0.8; Vitamin B12, 0.005 g; Biotin, 0.17 g; Vitamin C, 75 g; Choline, 166.7 g; Inositol, 58.3 777 
g; Ethoxyquin, 20.8 g; Copper, 2.5 g; Ferrous iron, 10.0 g; Magnesium, 16.6 g; Manganese, 15.0 g; Zinc, 25.0 g.  778 
 779 
 780 
781 
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Table 3. Nutrient composition of experimental diets  782 
   
 D1 D5 D10 D15 D20 D10A D10E D5E 
         
Dry matter (g/kg) 958 967 952 961 943 921 946 944 
Protein (g/kg DM) 525 526 511 513 521 519 517 518 
Fat (g/kg DM) 181 176 204 205 204 178 186 182 
Carbohydrate (g/kg DM) 186 239 230 253 206 214 194 213 
Ash (g/kg DM) 82 72 68 69 71 86 82 74 
Gross Energy (kJ/g) 22.3 22.4 23.1 22.7 22.1 22.7 22.5 23.0 
Protein:Energy (g/MJ) 23.5 23.5 22.1 22.6 23.6 22.9 23.0 22.5 
         
All fatty acid data are %TFA        
14:0 6.2 6.0 6.7 6.8 7.4 5.8 7.3 6.8 
16:0  21.5 20.6 21.5 22.9 23.7 20.7 21.9 22.5 
18:0  8.4 7.7 7.3 7.7 7.2 7.4 6.9 7.8 
Total SFA  36.7 34.4 35.9 37.3 38.7 34.9 36.6 37.4 
16:1n-7  1.4 1.3 1.8 1.9 2.1 1.4 5.1 3.2 
18:1n-9  49.7 48.2 44.3 42.5 39.2 38.8 35.5 43.5 
18:1n-7  4.0 3.9 3.7 3.7 3.7 3.1 3.8 4.0 
Total MUFA  56.0 54.1 51.1 49.1 46.0 44.1 45.8 51.7 
18:2n-6  5.8 6.7 5.9 5.3 4.9 6.5 5.6 6.1 
18:3n-3  0.5 0.8 0.6 0.5 0.5 0.6 0.7 0.6 
Total C18 PUFA  6.4 8.0 7.1 5.8 5.6 7.4 7.6 7.1 
20:4n-6  0.1 0.1 0.1 0.1 0.1 5.1 0.4 0.1 
20:5n-3  0.4 0.6 0.5 0.4 0.4 0.6 4.8 2.0 
22:5n-6  0.0 0.6 1.3 1.5 1.6 1.3 0.0 0.0 
22:5n-3  0.0 0.1 0.2 0.0 0.0 1.9 0.6 0.0 
22:6n-3  0.5 2.0 3.6 5.7 7.6 4.1 3.9 1.7 
Total LC-PUFA  1.0 3.4 5.8 7.8 9.8 13.5 10.0 3.8 
Total n-3  1.4 3.8 5.3 6.6 8.5 7.1 11.3 4.7 
Total n-6 5.9 7.7 7.7 6.9 6.8 13.8 6.3 6.2 
n-3 : n-6  0.24 0.49 0.69 0.96 1.25 0.52 1.78 0.76 
         
%TFA = percentage of total fatty acids.783 
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Tables 4. Growth, feed utilisation and survival over the 62-day experimental period.  
 
a D1 D5 D10 D15 D20 R2 F-value P-value 
         
Initial weight (g/fish) 110.8 112.5 110.7 113.7 109.2 0.022 0.070 0.808 
Final weight (g/fish) 226.8 226.7  233.1 232.1 231.4 0.564 3.880 0.143 
Weight gain (g/fish) 116.0  114.2  122.5 118.5 122.1 0.401 2.010 0.251 
Gain rate d0-d62 (g/d) 1.87  1.84  1.98  1.91  1.97 0.401 2.010 0.251 
Gain rate d42-d62 (g/d) 2.30 2.66 2.80 2.70 2.90 0.715 7.532 0.071 
Feed intake (g/fish) 106.3  105.9  108.5  105.3  107.3 0.025 0.078 0.797 
Feed Conversion (feed : gain) 0.95 0.96 0.90 0.90 0.90 0.534 3.440 0.161 
Survival (%) 83%  85%  90%  88%  90% 0.744 8.709 0.060 
         
 
b D1 D10 D20 D10A D10E D5E Pooled SEM 
        
Initial weight (g/fish) 110.8 110.7 109.2 111.8 111.0 108.0 0.53 
Final weight (g/fish) 226.8a 233.1 ab 231.4 ab 231.9 ab 238.9 b 229.6 ab 1.49 
Weight gain (g/fish) 116.0 a 122.5 ab 122.1 ab 120.1 ab 127.9 b 121.6 ab 1.39 
Gain rate d0-d62 (g/d) 1.87 a 1.98 ab 1.97 ab 1.94 ab 2.06 b 1.96 ab 0.02 
Gain rate d42-d62 (g/d) 2.30 a 2.80 b 2.90 b 2.99 b 2.92 b 2.75 ab 0.04 
Feed intake (g/fish) 106.3  108.5  107.3  105.0  107.4  106.1  0.43 
Feed Conversion (feed : gain) 0.95 b 0.90 ab 0.90 ab 0.91 ab 0.86 a 0.87 a 0.01 
Survival (%) 83%  90%  90%  82%  87%  93%  1.6% 
        
a, Diets D1, D5, D10, D15 and D20 with regression statistics against formulated DHA inclusion level in the diet. 
b, Diets D1, D10, D15, D20, D10A, D10E and D5E with results of ANOVA. Different superscript letters within a row indicates significant 
differences between means among treatments (P<0.05).  
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Table 5. Whole body proximate (g/kg live basis) and fatty acid (% of total) composition.  
 
 Initial D1 D5 D10 D15 D20 D10A D10E   D5E Pooled SEM 
           
Dry matter 268 279 277 279 277 272 271 277 281 1.3 
Protein 176 184 185 185 189 186 190 185 190 0.1 
Fat 48 a 67 b 68b 63 ab 65 ab 53 a 61 ab 64 ab 70 b 5.9 
Ash 19 28 21 26 24 24 24 25 26 3.1 
           
14:0 6.8 b 5.3 a 5.4 a 5.2 a 5.6 ab 5.6 ab 5.5 ab 5.9 ab 5.4 a 0.1 
16:0 19.6 b 18.3 a 18.6 ab 17.4 a 19.4 b 19.5 b 19.0 ab 19.3 b 18.5 ab 0.2 
18:0 4.6 a 5.8 b 5.8 b 5.3 a 5.6 ab 5.4 a 5.5 ab 5.5 ab 5.7 b 0.1 
Total SFA 33.0 b 30.5 a 30.7 a 29.1 a 31.6 ab 31.4 ab 31.0 ab 31.8 ab 30.5 a 0.3 
16:1n-7 9.0 c 4.6 a 4.5 a 4.4 a 4.7 ab 4.7 ab 4.5 a 6.1 b 4.9 ab 0.1 
18:1n-9 18.5 a 38.4c 39.3 c 36.9 bc 35.1 bc 33.1 bc 34.3 bc 31.8 b 37.6 c 0.6 
18:1n-7 4.1 3.7 3.8 3.7 3.8 3.7 3.5  4.2  4.0  0.1 
Total MUFA 34.6 a 50.1 c 51.0 c 48.4 bc 46.7 bc 44.2 b 44.7 b 45.0 bc 49.7 c 0.6 
18:2n-6 6.1  6.1  6.2  6.5  6.3  6.4  6.8  6.3  6.3  0.1 
18:3n-3 1.3 b 0.7 a 0.7 a 0.8 a 0.8 a 0.8 a 0.8 a 0.9 ab 0.7 a 0.1 
Total C18 PUFA 9.1 b 7.6 a 7.6 a 8.2 ab 7.6 a 7.9 a 8.4 ab 8.0 a 7.7 a 0.1 
20:4n-6 0.8 a 0.6 a 0.5 a 0.6 a 0.5 a 0.7 a 3.1 b 0.5 a 0.5 a 0.2 
20:5n-3 8.0 c 3.0 ab 2.5 a 2.9 a 3.1 ab 3.1 ab  2.9 a 4.0 b 3.0 ab 0.1 
22:5n-6 0.3 a 0.2 a 0.4 ab 0.9 b 1.0 b 1.6 c 1.0 b 0.2 a 0.1 a 0.1 
22:5n-3 2.6 b 1.1 a 0.9 a 1.2 a 1.1 a 1.1 a 1.0 a 1.5 ab 1.1 a 0.1 
22:6n-3 10.3 b 5.4 a 5.1 a 7.3 ab 7.2 ab 9.0 b 6.5 a 7.6 ab 6.1 a 0.3 
Total LC-PUFA 23.3 c 11.8 a 10.7 a 14.3 a 14.2 a 16.5 b 15.9 ab 15.2 ab 12.1 a 0.5 
Total n-3 24.5 b 11.1 a 10.0 a 13.3 a 12.9 a 15.1 a 12.1 a 15.2 a 11.7 a 0.5 
Total n-6 7.9 a 8.3 a 8.3 a 9.3 ab 8.9 a 9.4 ab 12.2 b 8.1 a 8.1 a 0.3 
n-3 : n-6 3.09 c 1.35 a 1.21 a 1.44 ab 1.44 ab 1.62 b 0.99 a 1.88 b 1.44 ab 0.1 
           
 Different superscripts indicate significant differences between means among treatments (P<0.05). Lack of a superscript 
implies that there were no significant differences. 
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Table 6. Plasma biochemistry and blood haematology parameters 
 
 Units D1 D5 D10 D15 D20 D10A D10E D5E Pooled SEM 
           
Alanine Aminotransferase IU L-1 6.0a 5.7 a 5.7 a 5.3 a 9.3 a 12.7 b 6.0 a 6.3 a 0.7 
Glutamate Dehydrogenase IU L-1 28.7 ab 28.3 ab 23.7 a 33.0 ab 38.0 b 35.7 ab 27.0 ab 31.0 ab 1.9 
Asparagine Aminotransferase IU L-1 234 ab 193 ab 188 a 202 ba 205 ab 246 b 194 ab 213 ab 7.6 
Creatine Kinase IU L-1 25973 17717 23790 18287 21653 25817 22777 24880 1749 
Creatinine µmol L-1 29.7 ab 27.3 a 28.0 a 26.3 a 25.7 a 31.3 b 33.0 b 29.3 ab 0.8 
Total Protein g L-1 38.0 a 40.3 a 39.3 a 40.0 a 39.7 a 40.0 a 44.7 b 42.3 ab 0.6 
Cholesterol mmol L-1 6.8 a 7.6 ab 7.7 ab 7.1 ab 6.9 a 6.2 a 7.5 ab 8.2 b 0.2 
Calcium mmol L
-1 
2.93 ab 2.93 ab 2.90 ab 2.90 ab 2.83 a 2.93 ab 3.00 b 2.97 b 0.02 
Potassium mmol L
-1 
4.3  3.9 3.8 4.4 4.5 3.6 3.8 4.5 0.2 
Sodium mmol L
-1 
168 b 168 b 164 ab 160 a 166 ab 164 ab 166 ab 164 ab 1.1 
Chloride mmol L
-1 
133  133 131 129 133 130 130 131 0.8 
Red Blood Cell Count x10
12 L-1 1.10 ab 1.20 b 1.10 ab 1.15 b 1.13 b 1.00 a 1.20 b 1.15 b 0.02 
White Blood Cell Count x109 L-1 32.1  33.4 19.3 28.1 31.3 28.3 23.6 18.2 1.9 
Haemoglobin g L-1 126.0 ab 132.0 b 123.0 ab 136.5 b 126.7 ab 130.0 ab 126.7 ab 121.0 a 1.3 
Packed Cell Volume mL mL-1 0.54  0.57 0.53 0.60 0.54 0.57 0.54 0.53 0.01 
           
Different superscripts indicate significant differences between means among treatments (P<0.05). Lack of a superscript implies that there were no significant differences. 
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Table 7. Clinical physical health assessment at the end of the 62-day experimental period. Other than gill score, data are 
percent (%) of total population presenting each symptom. 
 
 D1 D5 D10 D15 D20 D10A D10E D5E Pooled SEM 
          
Pin head 0 a 2 ab 2 ab 4 b 0 a 4 b 5 b 0 a 0.8 
Pectoral fin erosion 2 a 12 b 6 ab 2 a 0 a 0 a 13 b 4 a 1.5 
Caudal fin erosion 7 b 2 a 7 b 0 a 2 a 0 a 2 a 7 b 1.1 
Scale damage 2 a 6 ab 12 bc 0 a 4 a 19 c 2 a 0 a 2.3 
Eye damage 2 ab 0 a 2 ab 4 b 0 a 2 ab 0 a 2 ab 0.6 
AGD gill score 1.3 ab 1.6 ab 1.1 a 1.7 b 1.4 ab 1.5 ab 1.5 ab 1.4 ab 0.064 
                    
AGD : Amoebic Gill Disease. Score based on that reported in Taylor et al., 2009. All other data are reported as percentage of fish showing the particular clinical sign. 
 Different superscripts indicate significant differences between means among treatments (P<0.05). Lack of a superscript implies that there were no significant differences. 
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